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Lipoproteins are important components of the mycobacterial cell envelope due to their
function in cell wall homeostasis and bacterial virulence. They are post-translationally
modified with lipid- and glycosyl-residues in various species and interference with
acylation or glycosylation leads to reduced growth and attenuated virulence in
Mycobacterium tuberculosis. Lipoproteins are also expressed in the emerging and
highly drug resistant pathogen Mycobacterium abscessus which frequently affects the
lungs of patients with chronic pulmonary disease or cystic fibrosis. We investigated
post-translational modification, acylation and glycosylation, of heterologously expressed
(M. tuberculosis LppX and Mpt83) and endogenous (SodC) lipoproteins at the molecular
level in M. abscessus and identified MAB_1122c as protein O-mannosyltransferase
(Pmt). Both, heterologous and endogenous lipoproteins carried a characteristic
lipid anchor with palmitic acid (C16), palmitoleic acid (C16:1), oleic acid (C18), or
tuberculostearic acid (C19) modifications. Multiple hexose-moieties were detected
in the N-terminal region of the model lipoproteins expressed in M. abscessus.
Conservation of lipoprotein glycosylation in M. tuberculosis and M. abscessus was
revealed and points toward the existence of an O-glycosylation motif or other regulatory
mechanisms regarding this post-translational modification. Deletion of MAB_1122c
prevented glycosylation and affected susceptibility to specific antibiotics which are
large or target peptidoglycan synthesis and to lysozyme. Cell envelope permeability
of M. abscessus 1pmt was increased and mutant bacteria showed reduced survival
inside macrophages. The results provide a link between post-translational modification
of lipoproteins and the permeability of the mycobacterial cell envelope which stresses
the importance of lipoproteins as components of this complex structure.
Keywords: lipoprotein, glycosylation, Mycobacterium abscessus, post-translational modification, virulence, drug
susceptibility
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INTRODUCTION
The cell envelope of mycobacteria is comprised of a plasma
membrane, the periplasm and a lipid-rich mycobacterial outer
membrane which contains arabinogalactan and mycolic acids.
This thick and low-permeable structure contributes to persistence
and high intrinsic drug resistance of mycobacteria (Brennan
and Nikaido, 1995). Lipoproteins are important components
of the mycobacterial cell envelope and in mycobacterial
physiology since they fulfill various functions in membrane
homeostasis, transmembrane signaling and adhesion to host
cells (Sutcliffe and Harrington, 2004; Becker and Sander, 2016).
In Mycobacterium tuberculosis, approximately 100 putative
lipoproteins are expressed. They have been identified as
immunogenic antigens (for review see Becker and Sander,
2016) and virulence factors since interruption of the lipoprotein
synthesis pathway led to increased killing of bacilli inside
macrophages and improved survival of infected mice (Sander
et al., 2004; Rampini et al., 2008). LpqW for instance plays a
role in synthesis of crucial lipoglycans, the lipoarabinomannans
(Rainczuk et al., 2012) and RpfB (resuscitation promoting factor
B) is involved in cleavage of peptidoglycan during resuscitation
(Russell-Goldman et al., 2008). LppX mediates the transport of
complex lipids, the phthiocerol-dimycocerosates, to the outer
membrane where these serve as virulence factors (Sulzenbacher
et al., 2006). Mpt83 is described as an adhesion factor (Carr et al.,
2003). Lipoproteins are synthesized from pre-pro-lipoproteins
through the consecutive action of diacylglyceryltransferase (Lgt),
pro-lipoprotein signal peptidase (LspA) and N-acyltransferase
(Lnt) (Tschumi et al., 2009, 2012; Brulle et al., 2013).
These membrane-bound enzymes assemble the N-terminal
lipid anchor, comprised of a diacylglycerol- and an N-acyl
moiety, onto the conserved cysteine in the characteristic lipobox
(LVI/ASTVI/GAS/C) (Kovacs-Simon et al., 2011).
Next to their three acyl moieties, some mycobacterial
lipoproteins also carry glycosyl-residues. Protein
glycosylation in M. tuberculosis is mediated by two enzymes,
polyprenol-monophosphomannose-synthase (Ppm1) and
protein-O-mannosyltransferase (Pmt). A mannose residue is
transferred from the donor GDP-mannose to a polyprenol
phosphate carrier in the plasma membrane by Ppm1. The
mannosylated lipid carrier flips across the membrane so that the
hexose is exposed at the periplasmic site. There, Pmt catalyzes
the transfer of the mannose residue to a serine or threonine in
the polypeptide chain (VanderVen et al., 2005). In mycobacteria
to date only O-linked mannosylation has been described and
the modification has been shown to be Sec-export dependent
(Michell et al., 2003; VanderVen et al., 2005). Pmt might also be
responsible for glycosylation of non-lipoproteins but it is clearly
dispensable for synthesis of other crucial cell wall components
like lipomannans or lipoarabinomannans (Horn et al., 1999; Liu
et al., 2013). Lipoproteins are considered particularly important
substrates of Pmt with regard to cell envelope homeostasis. In
this study we investigate the effects of protein glycosylation
deficiency on the mycobacterial cell envelope and therefore
we focus on the lipoprotein glycosylating function of Pmt.
In M. tuberculosis, Mycobacterium smegmatis or the closely
related Corynebacterium glutamicum the lipoproteins LppX,
Mpt83, LprI, LpqH, LprG, and SodC have been found with
glycosyl-residues (Michell et al., 2003; Sartain and Belisle, 2009;
Mohiman et al., 2012; Sethi et al., 2016; Alonso et al., 2017;
Parra et al., 2017). The emerging pathogen Mycobacterium
abscessus, a highly drug resistant fast-growing mycobacterium
which infects the lungs of patients with chronic pulmonary
disease or cystic fibrosis, also localizes lipoproteins in its cell
envelope (Ripoll et al., 2009; Nessar et al., 2012). The bacteria’s
capability to post-translationally modify these proteins and the
effect of lipoprotein modification on M. abscessus homeostasis
and virulence have not been investigated yet.
Here, we elucidated lipoprotein modification in M. abscessus
at the molecular level. We characterized lipidation and
glycosylation of heterologously expressed M. tuberculosis and
endogenous M. abscessus lipoproteins by mass-spectrometry
and revealed conservation of O-glycosylation throughout fast-
and slow-growing mycobacterial species. The observation points
to a universal but to date unknown motif for this post-
translational modification. We identified MAB_1122c as Pmt,
the lipoprotein glycosylating enzyme in M. abscessus. The
role of lipoprotein glycosylation in M. abscessus cell envelope
homeostasis, antibiotic resistance, and virulence in an in vitro
model was assessed using a MAB_1122c deletion mutant.
We show that lipoprotein glycosylation deficiency increases
permeability of the M. abscessus cell envelope and alters
susceptibility to large and bulky compounds and to antibiotics
acting on the peptidoglycan layer. Furthermore, intracellular
survival of glycosylation deficient M. abscessus is compromised.
MATERIALS AND METHODS
Growth of Bacterial Strains
Mycobacterium abscessus was grown at 37◦C with daily manual
shaking in LB or Middlebrook 7H9-OADC-Tween supplemented
with apramycin (apra, 50 µg/ml), kanamycin (kan, 50 µg/ml),
or isoniazid (32 µg/ml) if required. Growth was monitored
by measuring OD600 and bacteria were transformed by
electroporation at 2.5 kV, 25 µF, 1000  as previously described
(Rominski et al., 2017a). Genomic DNA was isolated as described
by Sander et al. (1995). For drug susceptibility assays cation-
adjusted Müller-Hinton (CAMH) medium was used.
Generation of M. abscessus
1MAB_1122c
For deletion of the putative protein-O-mannosyltransferase
MAB_1122c, 1.5 kb upstream and downstream fragments
of MAB_1122c were amplified from M. abscessus genomic
DNA using primers 1122c_up_F/1122c_up_R and
1122c_down_F/1122c_down_R (see Supplementary Table
S1 for list of primers). Amplified fragments were cloned stepwise
into the pSE-apra-KatG vector (Rominski et al., 2017c) using
PscI/KpnI and KpnI/XbaI linkers for the up and down fragment,
respectively. After transformation of the pSE-MAB1122c-KO
vector into M. abscessus, selection with apramycin (positive)
and isoniazid (negative) led to the unmarked deletion of
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MAB_1122c. Southern Blot analyses with probes I and II that
were amplified from M. abscessus genomic DNA using primers
PI_1122c_F/PI_1122c_R and PII_1122c_F/PII_1122c_R,
respectively, verified recombination. For complementation,
the MAB_1122c gene including its native promotor region
was amplified from M. abscessus genomic DNA with primers
C_1122c_F and C_1122c_R and inserted into the pMV361-
kan vector via KpnI thereby generating pMV361-MAB1122c.
Integration of the complementation vector in the M. abscessus
1pmt genome was confirmed by Southern Blot.
Lipoprotein Expression
Genes encoding LppX (Rv2945c; 702 bp) and Mpt83 (Rv2873;
663 bp) were amplified from M. tuberculosis genomic DNA
with primers which introduce C-terminal, thrombin cleavable
His- and HA- tags and allow fusion to selected promoters
(LppX_F/LppX_R; Mpt83_F/Mpt83_R) (Supplementary
Table S1). The 19 kDa and the pfbpB promoter were
amplified from M. tuberculosis genomic DNA with primers
19 kDa_F/19 kDa_R and pfbpB_F/pfbpB_R. A fusion PCR with
primers 19 kDa_F/LppX_R as well as pfbpB_F/Mpt83_R was
performed to link the LppX and Mpt83 genes to the 19 kDa and
pfbpB promoter, respectively. The fused pfbpB-Mpt83 sequence
was cloned into the polyG-apra vector via HindIII and PstI.
The fused 19 kDa-LppX sequence was first integrated into the
pMV261-gentamicin vector then excised for insertion into the
polyG-apra vector with HindIII and PstI. Gibson cloning (Bordat
et al., 2015) was applied to insert endogenous M. abscessus
SodC (MAB_4184c) into the polyG-apra vector. The gene
(716 bp) was amplified from M. abscessus genomic DNA with
primers SodC_F and SodC_R, introducing a Thrombin-cleavable
His-and HA-Tag as well. The polyG-apra vector including the
pfbpB promoter was amplified in two separate fragments from
polyG-pfbpB-Mpt83 with primers polyG_a_F/polyG_a_R and
polyG_b_F/polyG_b_R. Assembly was performed as described
by Bordat et al. (2015).
Upon transformation of polyG-apra-LppX, polyG-apra-
Mpt83, and polyG-apra-SodC into M. abscessus strains (see list of
all strains used in this study in Supplementary Table S2), clones
were selected on LB plates supplemented with apramycin and
tested for protein expression by Western Blot. In brief, cells were
harvested from liquid culture and disrupted with acid washed
glass beads (≤106 µm, Sigma-Aldrich, Switzerland) in the
FastPep system (4x 1 min at 6 m/s; MP Bio, United States). The
lysate was loaded on a 12.5% Tris-HCl SDS Page gel (Criterion,
BioRad, Switzerland) and proteins were detected with primary
mouse anti-HA (1.300, Roche, Switzerland) and secondary goat
anti-mouse-HRP (1:20,000, LabForce, Switzerland) antibodies.
Protein Purification
Mycobacterium abscessus strains constitutively expressing LppX,
Mpt83, or SodC were harvested and disrupted by FastPrep.
Lysates were incubated with 2% N-Lauroylsarcosine sodium salt
(SLS; Sigma-Aldrich, Switzerland) for 1 h at room temperature
and kept at 4◦C overnight. Ultracentrifugation for 1 h at
100,000 × g was applied to separate membrane fragments
and unbroken cells from the solubilized lipoproteins. The
lipoprotein containing supernatant after ultracentrifugation
was diluted with dilution buffer (20 mM NaH2PO4, 0.5 M
NaCl, 0.2% SLS, pH = 7.4) in a 1:1 ratio and loaded onto
a Ni2+-column (His-Trap, GE Healthcare; Germany).
Proteins were gradually eluted with elution buffer (20 mM
NaH2PO4, 0.5 M NaCl, 0.2% SLS, 0.5 M imidazole,
pH = 7.4) by fast-protein-liquid-chromatography (FPLC)
using the ÄKTA Prime System (Amersham Bioscience, United
Kingdom).
Mass-Spectrometry
MALDI-TOF
Lipoprotein containing fractions after FPLC were precipitated
with trichloroacetic acid (TCA) and separated on a 12.5% Tris-
HCl SDS Page gel (Criterion, BioRad, Switzerland). Lipoprotein
bands visualized with 0.3 M copper-chloride staining were
excised and in-gel protein digestion with AspN was performed.
Peptides were treated according to the Ujihara method as
previously described (Ujihara et al., 2008) and samples were
analyzed on an Ultraflex II MALDI-TOF/TOF instrument
(Bruker, Germany) as noted by Tschumi et al. (2009). A mass
tolerance of m/z≈1 was applied for the selection of modified
peptide and fragment ions.
LC-ESI-MS
Pure fractions of lipoproteins were precipitated with TCA and
resuspended in NH4HCO3 buffer (pH= 8.3) supplemented with
15% methanol and 1% dithiothreitol (DTT). Disulfide bonds
were reduced with DTT at 50◦C for 30 min and cysteines
were alkylated by addition of 20 mM iodoacetamide at room
temperature in the dark. Lipoproteins were digested with trypsin
or AspN overnight at 37◦C. Sample clean-up was performed
with C18 ZipTips (Merck, Germany). Glycosylated peptide ions
were identified by LC-ESI-MS/MS analysis with an Orbitrap
Fusion mass-spectrometer (Thermo Fisher, Germany). Global
settings included the method duration of 110 min and a spray
voltage of 2000–2300 V for the positive ion and 600 V for
the negative ion. MS-data were detected in the Orbitrap at a
resolution of 120 k. The scan range was set to m/z = 400–
2000 and the maximum injection time was 50 ms. The AGC
Target value was 400,000. Peptide ions with a charge state of
2–7 were included and dynamic exclusion for 5 s after the
first measurement was applied. A mass tolerance of 10 ppm
was allowed. The minimum and maximum intensity thresholds
were set to 50,000 and 1 × 1020, respectively. MS/MS-data
were obtained upon higher-energy collision dissociation (HCD)
fragmentation. Collision Energy was set to 30% and fragment
ions were detected in the Orbitrap at a resolution of 120 k
as well. The maximum injection time for MS/MS was 250 ms.
The AGC Target value was set to 200,000 and one microscan
was performed. Results were interpreted with Mascot using a
database of mycobacterial protein sequences and allowing two
missed cleavages and a mass tolerance of 0.04 Da for MS/MS-
data. Carbamidomethyl (C) as a fixed modification and Gln
→pyro-Glu (N-term Q), Oxidation (M), Hex-CID/HCD (S),
and Hex-CID/HCD (T) as variable modifications were selected.
Identified glycopeptides were confirmed by manual analyses of
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spectra. Detailed Mascot results of the analyses can be found in
Supplementary Table S3.
Minimal Inhibitory Concentration (MIC)
Assay
Minimal inhibitory concentration (MIC) determination was
performed according to the guidelines of the Clinical and
Laboratory Standards Institute with the exception that incubation
was at 37◦C rather than at 30◦C and as previously described
(Rominski et al., 2017a). A fourfold difference in MIC values
was considered significant. Ethambutol, isoniazid, bacitracin,
vancomycin, rifampicin, and amikacin were dissolved in water
and stored at−20◦C until usage. Cefoxitin, ceftriaxone, penicillin
G, and ampicillin were dissolved in water, aliquoted and
stored as described by Rominski et al. (2017b). For the
checkerboard MIC assay, twofold microdilutions of lysozyme
(0.016–2 mg/ml) combined with bacitracin (0.5–64 mg/l) or
vancomycin (0.008–1 mg/l) were produced in a 96-well plate
format by an automated platform (Tecan Freedom EVO 100,
Switzerland). Inocula were determined for all experiments at
day 5 and experiments were validated when 4 × 105 to
1.3 × 106 CFUs/ml were counted. All MIC values were
determined in three independent experiments after 5 days
of growth at 37◦C and the median of the measurements is
depicted.
Permeability Assay
Mycobacterium abscessus WT, 1pmt and 1pmt::pmt cultures
in exponential growth phase were harvested, diluted to
OD600 nm= 0.5 in uptake buffer (50 mM KH2PO4, 5 mM MgSO4,
pH = 7) and re-energized with 25 mM glucose. In a 96-well
plate format, basic fluorescence (emission: 530 nm/extinction:
590 nm) was measured at t−2 min. 20 µM ethidium bromide
was added to each sample subsequently. 0.1 mM Carbonyl-
Cyanide 3-Chlorophenylhydrazone (CCCP) was used to control
for the role of eﬄux pumps in ethidium bromide mediated
fluorescence. Measurements were performed in triplicates and
kinetics of ethidium bromide uptake were monitored from t0 min
on for 40 min at room temperature in a microplate reader
(Bio Tek Synergy HT, Switzerland). Results were normalized
against auto fluorescence of ethidium bromide and are depicted
relative to the highest fluorescence measured. Statistical analysis
of significance was performed by one-way ANOVA and Tukey’s
Multiple Comparison Test (P < 0.05).
Intracellular Survival Assay
Intracellular survival of M. abscessus strains in THP-1
macrophages was investigated as previously described (Roux
et al., 2016). Macrophages were infected with bacteria at an MOI
in the range of 0.2–2 for 2 h at 37◦C. Extracellular bacteria were
removed by extensive washes with PBS followed by incubation
of cells with RPMI medium containing 250 µg/ml amikacin.
After 1 h, amikacin concentration in the medium was reduced to
50 µg/ml for the remaining experiment. Statistical analysis of the
results was performed by one-way ANOVA and Tukey’s Multiple
Comparison Test (P < 0.001).
RESULTS
Lipoprotein Acylation in M. abscessus
Mycobacterium tuberculosis LppX (Rv2945c) and Mpt83
(Rv2873) were chosen as model lipoproteins for the analysis
of acylation and glycosylation in M. abscessus. These proteins
are stable, not toxic, and known to carry both modifications
in other mycobacteria (Michell et al., 2003; Tschumi et al.,
2009, 2012; Mohiman et al., 2012; Brulle et al., 2013). We also
investigated SodC (MAB_4184c) as an endogenous M. abscessus
protein which shows 61% homology to the lipidated and
glycosylated M. tuberculosis protein (Rv0432) (Sartain and
Belisle, 2009). Lipoprotein expression vectors polyG-apra-LppX,
polyG-apra-Mpt83 and polyG-apra-SodC were transformed
into M. abscessus for the expression of full-length His- and
HA-tagged proteins. These were isolated by FPLC and analyzed
by mass-spectrometry. The N-terminal peptide of heterologously
expressed Mpt83 (AspN-digestion fragment: CSSTKPVSQ) was
modified with palmitic acid/oleic acid (C16/C18) diacylglycerol
as indicated by the detected peptide ion at m/z = 1513.899
(Figure 1A). This peptide ion was also identified with one
additional hexose at m/z = 1674.183 (Figure 1B). A palmitic
acid (C16) N-acyl modification in addition to the diacylglycerol
and the hexose was found on the peptide ion at m/z = 1909.970
(Figure 1C). Fragmentation of these peptide ions in the MALDI-
TOF/TOF analysis revealed the elimination of various fragments
which confirmed the modifications (Figure 1D). Also LppX
and SodC were shown to carry the characteristic lipid anchor
of lipoproteins. Heterologously expressed LppX was modified
with palmitic acid/oleic acid (C16/C18) diacylglycerol and a
palmitic acid (C16) N-acyl residue in M. abscessus. Indication
for a tuberculostearic acid/tuberculostearic acid (C19/C19)
diacylglycerol modification at the N-terminal peptide of LppX
(AspN-digestion fragment: CSSPKP) was obtained as well
(Table 1). The N-terminal peptide of SodC (AspN-digestion
fragment: CSP) was detected with a palmitoleic acid/oleic acid
(C16:1/C18) diacylglycerol modification and one additional
hexose (Table 1). The enzymatic machinery to synthesize tri-
acylated lipoproteins at the conserved cysteine in their lipobox
is thus present in M. abscessus. In silico homology searches with
M. tuberculosis Lgt, LspA, and Lnt protein sequences identified
MAB_2642c, MAB_2700c, and MAB_2206 as M. abscessus
homologs.
MAB_1122c Is a Putative
Protein-O-Mannosyltransferase in
M. abscessus
In order to identify the gene responsible for the second post-
translational modification on lipoproteins, we searched for
homologs of mycobacterial lipoprotein glycosylating enzymes
in M. abscessus. We performed an in silico search with
M. tuberculosis (Rv1002) and M. smegmatis (Msmeg_5447)
Pmt in M. abscessus ATTCC 19977 and identified MAB_1122c
as putative Pmt with 68% homology to the M. tuberculosis
and the M. smegmatis protein, respectively. In order to
confirm gene annotation and to assess the role of lipoprotein
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FIGURE 1 | MALDI-TOF/TOF analysis of Mpt83 (Rv2873) acylation in Mycobacterium abscessus WT. (A) MS/MS spectrum of the N-terminal peptide ion of Mpt83
(CSSTKPVSQ) with palmitic acid/oleic acid (C16/C18) diacylglycerol modification (calculated m/z = 1513.355). Elimination of a palmitic acid-thiol-glyceryl (calculated
m/z = 327.56) was observed. (B) MS/MS spectrum of the N-terminal peptide ion of Mpt83 with palmitic acid/ oleic acid (C16/C18) diacylglycerol + one hexose
modification (calculated m/z = 1674.6). Elimination of a palmitic acid-thiol-glyceryl (calculated m/z = 327.56), the hexose (calculated m/z = 162.05) and oleic
acid-thiol-glyceryl (calculated m/z = 353.66) was observed. (C) MS/MS spectrum of the N-terminal peptide ion of Mpt83 with palmitic acid/oleic acid (C16/C18)
diacylglycerol + palmitic acid (C16) N-acyl + one hexose modification (calculated m/z = 1910.0). Elimination of palmitic acid-thiol-glyceryl (calculated m/z = 327.56),
the hexose (calculated m/z = 162.05), oleic acid-thiol-glyceryl (calculated m/z = 353.66), oleic acid (calculated m/z = 281.5) and the palmitic acid/ oleic acid
diacylglycerol (calculated m/z = 578.0) was observed. (D) Chemical structures of the eliminated fragments are depicted: (1) palmitic acid-thiol-glyceryl, (2) hexose,
(3) oleic acid-thiol-glyceryl, (4) oleic acid, and (5) palmitic acid/oleic acid diacylglycerol.
glycosylation in the bacteria’s physiology we generated an
unmarked MAB_1122c deletion mutant by transformation
of M. abscessus with the allelic replacement vector pSE-
MAB1122c-KO (Figure 2A). Single crossover transformants
were selected on agar plates containing apramycin and identified
by Southern Blot analysis (Figures 2A,B). Transformants were
subsequently subjected to counter selection in the presence of
isoniazid and also analyzed by Southern Blot (Figures 2A,B).
The M. abscessus 1pmt mutant was transformed with the
complementation vector pMV361-MAB1122c. Genomic DNA
was used to confirm integration of the vector by Southern Blot
(Figures 2A,B).
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TABLE 1 | Lipidation of heterologous and native lipoproteins in M. abscessus.
MS MS/MS
Protein Peptide modification Calculated m/z Observed m/z Eliminated fragment Calculated
m/z
Observed
m/z
LppX (Rv2945c) CSSPKP
+ Diacylglycerol (C16/C18)
1194.812 1195.202 C16/C18 diacylglyceryl
C16/C18-thio-gIyceryI
616.82
585.72
616.287
586.134
CSSPKP
+ Diacylglycerol (C16/C18)
+ N-acyl (C16)
1595.741 1595.843 1 Hex
C18-thio-glyceryl ester
+ 1 Hex
1433.691
1080.031
1434.299
1080.294
CSSPKP
+ Diacylglycerol (C19/C19)
1252.805 1253.342 C19/C19 diacylglycerol 616.705 616.096
SodC (MAB_4184c) CSP
+ Diacylglycerol (C16:1/C18)
881.274 881.022 C16:1/C18 diacylglyceryl
C18-thio-glyceryl ester
305.274
527.614
305.084
527.614
CSP
+ Diacylglycerol (C16:1/C18)
+1 Hex
1043.611 1043.263 C16:1/C18 diacylglyceryl
+1 Hex
C16:1-thio-glyceryl ester
305.274
718.051
305.100
717.495
FIGURE 2 | MAB_1122c deletion in M. abscessus. (A) Upon transformation of the allelic replacement vector pSE-MAB1122c-KO vector and positive selection
(apramycin), homologous recombination in the down-fragment created a 3′ single crossover (3′ SCO). Subsequent second homologous recombination and negative
selection (isoniazid) led to an unmarked knockout (1). Complementation was achieved through integration of the pMV361-MAB1122c vector (cw and acw
orientation) at the attP site. A Van91I digest and two probes, in the up-fragment (probe I) and in the MAB_1122c gene (probe II), were used to verify each genotype
by Southern Blot. (B) Southern Blot analysis of genomic DNA from MAB WT, 3′ SCO, MAB_1122c knockout (1) and the complemented strains (COI and COII)
confirmed the genotypes. Probe I and II generated identical bands for M. abscessus WT (2734 bp) and 3′ SCO (Probe I: 2734 bp/5031 bp; Probe II: 2734 bp). The
MAB_1122c deletion (1) hybridizes with probe I (3152 bp) while probe II detects the complemented genotypes (COI: 3047; COII: 2546).
Protein-O-Mannosyltransferase
(MAB_1122c) Glycosylates Lipoproteins
in M. abscessus
Heterologous expression of LppX (Rv2945c) and Mpt83
(Rv2873) in M. abscessus WT, 1pmt and 1pmt::pmt and
subsequent LC-ESI-MS analysis revealed that in M. abscessus
WT the lipoprotein LppX is glycosylated with one to two hexoses
(Figure 3A). Mpt83 was more extensively glycosylated with
up to six hexoses (Table 2). Glycosylated peptide ions eluted
earlier than non-glycosylated peptide ions from the liquid-
chromatography column due to increased hydrophilicity [see
retention time (RT); Table 2]. All hexoses, presumably mannoses
as described for other mycobacteria (Dobos et al., 1996; Michell
et al., 2003), were identified in the tryptic N-terminal peptides
(LppX: SSPKPDAEEQGVPVSPTASDPALLAEIR/ Mpt83: PAT
SPAAPVTTAAMADPAADLIGR). Analysis of lipoprotein
glycosylation in M. abscessus WT compared to M. abscessus
1pmt and M. abscessus 1pmt::pmt revealed that MAB_1122c
encodes for Pmt and is essential for lipoprotein glycosylation
in M. abscessus. LppX purified from M. abscessus 1pmt was
not glycosylated (Figure 3B) but glycosylation was restored in
the complemented strain (Figure 3C). Mpt83 glycosylation was
also abolished in M. abscessus 1pmt but was fully restored in
the complemented M. abscessus 1pmt::pmt strain (Table 2).
The identity of modified peptide ions was confirmed by manual
analysis of corresponding MS/MS-spectra (Figure 3D). Due to
the loss of glycosylation during HCD-fragmentation, the MS/MS-
spectrum depicted in Figure 3D is representative both for the
glycosylated and non-glycosylated N-terminal peptide ion of
LppX (see Supplementary Table S4 for predicted fragment ions).
In order to confirm that also endogenous M. abscessus proteins
are glycosylated, we recombinantly expressed and subsequently
analyzed M. abscessus SodC (MAB_4184c). LC-ESI-MS
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FIGURE 3 | Glycosylation of LppX (Rv2945c) in M. abscessus. (A–C) Mass-spectra representative for LC-ESI-MS analyses of LppX purified from M. abscessus WT,
1pmt and 1pmt::pmt are shown. The N-terminal, tryptic peptide ion (SSPKPDAEEQGVPVSPTASDPALLAEIR) of LppX was detected unmodified (calculated
m/z = 954.489, 3+), with one hexose (calculated m/z = 1008.505, 3+) and with two hexoses (calculated m/z = 1062.522, 3+) in M. abscessus WT (A) and
M. abscessus 1pmt::pmt (C). Differences of m/z = 162.05/3 = 54 between the peptide ion peaks reflect hexose modification (green dot). In M. abscessus 1pmt
only the unmodified peptide ion (calculated m/z = 954.489, 3+) was detected (B). (D) The MS/MS spectrum of the unmodified peptide ion found in M. abscessus
WT (depicted) is also representative for the N-terminal peptide ions of LppX from M. abscessus 1pmt and 1pmt::pmt since glycosylation is eliminated during
higher-energy collision dissociation (HCD) fragmentation. Detection of predicted fragment ions (y- and b-ions; Supplementary Table S3) confirms the identity of
modified and unmodified peptide ions.
analysis indicated that this protein is glycosylated with up
to nine hexoses in M. abscessus WT. Glycosylation sites were
located in the N-terminal peptide (AspN-digestion fragment:
DQQASTTPGTTPPVWTGSTAPATAGEHGGHGGGEQPVPA
GEKLNATLKLA; Table 3). Identification of glycosylation of
M. abscessus SodC indicated that also endogenous lipoproteins
are glycosylated by Pmt (MAB_1122c) in M. abscessus.
M. abscessus 1pmt Is Susceptible to
Bulky Antibiotics and to Compounds
Acting on Peptidoglycan
The effect of lipoprotein glycosylation deficiency on antibiotic
susceptibility of M. abscessus was assessed in a MIC assay.
M. abscessus 1pmt showed increased susceptibility to all
tested β-lactams (cefoxitin, ceftriaxone, penicillin G, and
ampicillin) as well as to the high molecular weight antibiotics
(Supplementary Figure S1) bacitracin (MIC = 256 mg/l),
vancomycin (MIC = 4 mg/l), and rifampicin (MIC = 64 mg/l).
Also susceptibility to lysozyme (MIC = 0.5 mg/ml) was elevated
(Table 4). In contrast, susceptibility to smaller antibiotics
interfering with the synthesis of other cell wall components
(ethambutol, isoniazid) or affecting translation (amikacin) was
not altered. Tolerance for the β-lactams, bacitracin, vancomycin,
rifampicin, and lysozyme comparable to that seen in WT bacteria
was restored in M. abscessus 1pmt::pmt. In order to investigate
potential synergistic effects between the bulky and peptidoglycan
affecting antibiotics bacitracin/vancomycin and lysozyme we
conducted a checkerboard titration assay. Specifically, we
tested subinhibitory concentrations of these antibiotics in
combination with the peptidoglycan cleaving enzyme. Highest
antibiotic concentrations tested were fourfold below MIC values
determined for M. abscessus 1pmt (Table 4). The maximum
tolerated concentrations of antibiotic and lysozyme are depicted
in Figure 4. Susceptibility of M. abscessus WT and M. abscessus
1pmt::pmt to the antibiotics and lysozyme was unaffected by
the combination of these compounds (Figures 4A,B). However,
M. abscessus 1pmt became more susceptible to lysozyme with
increasing concentrations of bacitracin. At the highest bacitracin
concentration, which is still fourfold below the MIC value
for M. abscessus 1pmt, as little as 0.02 mg/ml lysozyme were
tolerated (Figure 4A). This observation indicates synergistic
effects of lysozyme and bacitracin against M. abscessus 1pmt.
Tolerated concentrations of lysozyme remained at 0.25 mg/ml
until vancomycin concentrations rose to 0.5 and 1 mg/l
(Figure 4B). Since only higher concentrations of vancomycin
affected susceptibility of M. abscessus 1pmt to lysozyme,
vancomycin and lysozyme exhibit weaker synergistic effects.
Increased Cell Wall Permeability in
M. abscessus 1pmt
Based on the susceptibility of M. abscessus 1pmt to large
antibiotics which affect peptidoglycan and the observed
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TABLE 2 | Glycosylation of Mpt83 (Rv2873) in M. abscessus WT, 1pmt and 1pmt::pmt.
Mpt83 (Rv2873)
K.PATSPAAPVTTAAMADPAADLIGR.G + Oxidation (M)
WT 1pmf 1pmt::pmt
Glycosylation Calculated m/z Observed m/z z RT Observed m/z z RT Observed m/z z RT
No hexose 761.05 761.05 3+ 46.3 761.05 3+ 46.25 761.05 3+ 46.2
1 Hexose 815.07 815.072 3+ 44.69 815.07 3+ 44.56
2 Hexoses 869.09 869.09 3+ 42.18 869.08 3+ 42.23
3 Hexoses 923.10 923.10 3+ 41.32 923.1 3+ 41.28
4 Hexoses 977.12 977.12 3+ 40.9 977.12 3+ 40.08
5 Hexoses 1031.14 1031.14 3+ 39.53 1031.14 3+ 39.47
6 Hexoses 1085.15 1085.15 3+ 38.76 1085.15 3+ 38.95
TABLE 3 | Glycosylation of SodC (MAB_4148c) in M. abscessus WT.
SodC (MAB_4184c)
P.DQQASTTPGTTPPVWTGSTAPATAGEHGGHGGGE QPVPAGEKLNATLKLA.D
WT
Glycosylation Calculated m/z Observed m/z z RT
No hexose 970.67 970.485 5+ 65.97
1 Hexose 1003.08 1002.895 5+ 64.33
2 Hexoses 1035.49 1035.305 5+ 63.32
3 Hexoses 19067.90 1067.715 5+ 62.77
4 Hexoses 1100.32 1100.125 5+ 61.06
5 Hexoses 1132.72 1132.535 5+ 59.69
6 Hexoses 1165.13 1164.945 5+ 59.02
7 Hexoses 1197.54 1197.357 5+ 58.87
8 Hexoses 1229.95 1229.767 5+ 57.96
9 Hexoses 1262.36 1262.175 5+ 57.63
synergistic effects with lysozyme, we hypothesized that the
permeability of the cell envelope of this strain might be
increased due to structural effects of lipoprotein glycosylation
deficiency. We therefore conducted an ethidium bromide
uptake assay to test for altered permeability in the MAB_1122c
deletion mutant. Relative fluorescent intensity measurements
indicated that M. abscessus 1pmt takes up ethidium bromide
more efficiently than M. abscessus WT and M. abscessus
1pmt::pmt (Figure 5A). This elevated level of ethidium
bromide uptake in the mutant strain was also observed
upon inhibition of eﬄux processes with 0.1 mM CCCP
while overall fluorescent intensity in all strains was higher
due to increased ethidium bromide accumulation. The
total increase in fluorescent intensity after 40 min was
significantly higher in M. abscessus 1pmt as compared to
WT and the complemented strain both with and without
CCCP treatment (Figure 5B). Combined, these results point
toward an increased permeability of the M. abscessus 1pmt cell
envelope.
Glycosylation Deficiency Reduces
Intracellular Survival of M. abscessus
1pmt
In vitro growth of M. abscessus strains was assessed in
Middlebrook 7H9-OADC-Tween medium at 37◦C with regular
shaking and no difference in growth rate was observed between
M. abscessus WT, 1pmt and 1pmt::pmt (Figure 5C). In order
to investigate potential effects of glycosylation deficiency on
virulence of M. abscessus we conducted an intracellular survival
assay with the human monocyte-macrophage THP-1 cell line.
M. abscessus WT and M. abscessus1pmt::pmt survived inside the
macrophages during a 3 days course of infection (Figure 5D).
CFU counts for M. abscessus 1pmt significantly decreased by
0.8 log within 3 days of infection as compared to day 0
(Figure 5D). This indicates killing of M. abscessus 1pmt inside
infected macrophages and represents virulence attenuation of the
MAB_1122c deletion mutant as compared to M. abscessus WT
and M. abscessus1pmt::pmt.
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DISCUSSION
In this study we investigated post-translational modification of
lipoproteins and the function of lipoprotein glycosylation in the
emerging pathogen M. abscessus. We show that M. abscessus
tri-acylates lipoproteins with fatty acids obtained from the
phospholipids in its plasma membrane. The observed lipid
modifications include palmitic acid (C16), oleic acid (C18),
palmitoleic acid (C16:1), and tuberculostearic acid (C19).
Consistently with observations in M. smegmatis and M. bovis
BCG, the membrane anchor of lipoproteins in M. abscessus
is comprised of a heterogeneous combination of fatty acids
which can vary per protein-molecule (Brulle et al., 2013). We
demonstrate that lipoproteins can be glycosylated with a variable
number of hexoses in M. abscessus. This modification is mediated
by MAB_1122c which encodes for Pmt and is essential for
lipoprotein glycosylation in the emerging pathogen. Modification
by Pmt marks the first step in lipoprotein glycosylation in which
the mannose is attached to the exported protein (Liu et al., 2013).
Consequently, lipoprotein glycosylation in M. abscessus 1pmt is
abolished completely. All glycosyl-residues in M. abscessus were
detected in the N-terminal region of the model lipoproteins as
described for lipoproteins expressed in other mycobacteria as
well (Herrmann et al., 1996; Michell et al., 2003; Sartain and
Belisle, 2009; Mohiman et al., 2012; Sethi et al., 2016; Parra et al.,
2017). This observation indicates the existence of a conserved
motif which is recognized by Pmt from various mycobacterial
species and directs site-specific glycosylation of lipoproteins in
fast-and slow-growing mycobacteria (Sartain and Belisle, 2009;
Smith et al., 2014). Our notion, that heterologously expressed
lipoproteins like Mpt83 carry glycosyl-residues in the same
N-terminal region and probably at identical residues as when
expressed in their native environment supports this hypothesis
(Michell et al., 2003). Despite intensive investigations by Smith
et al. (2014) the potential consensus sequence for O-glycosylation
sites has to be further defined and verified in mycobacteria.
Another possible explanation for the exclusive and conserved
localization of glycosyl-moieties could be that only serine or
threonine residues in the N-terminal region of lipoproteins are
TABLE 4 | Antibiotic susceptibility of M. abscessus WT, 1pmt and 1pmt::pmt.
Strain
Compound (mg/l) WT Apmf Apmt::pmt
Ethambutol 64 64 64
Isoniazid 512 1024 512
Bacitracin >2048 256 >2048
Vancomycin 128 4 128
Rifampicin 256 64 256
Amikacin 2 2 2
Cefoxitin 64 16 32
Ceftriaxone 128 32 128
Penicillin >512 256 >512
Ampicillin >512 128 >512
Lysozyme >2000 500 >2000
accessible for Pmt during Sec-export. The SodC protein was
detected with up to nine mannoses in M. tuberculosis (Sartain
and Belisle, 2009) and carried the same number of hexoses in
M. abscessus. However, a mechanism for glycosyl-chain length
control in mycobacteria is unknown to date. It is also not clear yet
whether detected mannoses are attached to one amino acid each
or whether oligosaccharide chains are formed in M. abscessus.
Extensive glycosylation as seen for Mpt83 and SodC, however,
suggests that at least short mannose chains occur. Elongation of
these would be performed not by Pmt but by PimE (Rv1159),
an enzyme also involved in the synthesis of other membrane
components such as LMs and LAMs where it mediates the
addition of α-(1,2) linked mannoses to PIM molecules (Liu
et al., 2013). In M. abscessus MAB_1304 has 64% homology to
M. tuberculosis PimE.
Next to the structural analysis of lipoprotein modification
we show that glycosylation deficiency in M. abscessus alters
bacterial susceptibility to large and bulky compounds and to
drugs and enzymes which affect peptidoglycan. Due to their
thick and almost impermeable outer membrane like structure
and the expression of β-lactamases mycobacteria are usually
not susceptible to antibiotics acting on the peptidoglycan layer
(Brennan and Nikaido, 1995; Nessar et al., 2012). Nevertheless,
we observed synergistic effects of both bacitracin and vancomycin
with lysozyme in the 1pmt strain. We confirmed by in
silico analysis that M. abscessus does not express a homolog
of the lysozyme inhibitor LprI which has been described in
M. tuberculosis recently and could affect lysozyme MIC-testing
(Sethi et al., 2016). Particularly the antimicrobial activity of
the bacitracin-lysozyme combination was strong. The observed
effects on antibiotic susceptibility and intracellular survival might
occur due to structural alterations in the cellular envelope of
M. abscessus 1pmt upon lipoprotein glycosylation deficiency.
This hypothesis is in line with the increased cell envelope
permeability seen in the ethidium bromide uptake assay and
could explain why particularly large antibiotics like bacitracin,
vancomycin, and rifampicin (Supplementary Figure S1) can
affect the mutant and why the β-lactams can better reach their
target, the peptidoglycan layer. Also for theM. tuberculosisRpfnull
mutant deficient for all five mycobacterial Rpfs it was described
that the permeability of the outer membrane like structure is
increased which led to a change in susceptibility to various
β-lactams (Wivagg et al., 2014). This observation supports the
link between an altered cell wall homeostasis and increased
susceptibility to a broad range of large and bulky as well as to
peptidoglycan affecting compounds which we describe in this
study for the M. abscessus 1pmt mutant. The details of how
lipoprotein glycosylation deficiency affects cell permeability and
drug susceptibility of M. abscessus, however, remain elusive. One
possibility is that specific lipoproteins lose function without their
post-translational modification but to date there is no indication
for a functional requirement of glycosylation on lipoproteins.
For SodC it was shown that glycosylation deficiency affects
localization of the lipoprotein but is dispensable for its function
(Sartain and Belisle, 2009). Also for LprI in M. tuberculosis it
was reported that glycosylation is crucial for correct localization
of the protein (Sethi et al., 2016). It is therefore likely that the
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FIGURE 4 | Synergistic effects of bacitracin and vancomycin with lysozyme. Antibiotic dilution series starting with concentrations fourfold below the MIC value for
bacitracin (A) and vancomycin (B) determined for M. abscessus 1pmt were combined with lysozyme concentrations of 0.016–2 mg/ml. Maximum tolerated
concentrations of both compounds are depicted for M. abscessus WT (∗), 1pmt (•) and 1pmt::pmt ( _ ). Results of three independent experiments are represented
and the median of tolerated concentrations with the range of all measurements is shown.
FIGURE 5 | Permeability and virulence of M. abscessus WT, 1pmt and 1pmt::pmt. (A) Fluorescent intensity of M. abscessus cultures at t −2 min and after
subsequent addition of ethidium bromide was measured to detect uptake and incorporation of the fluorescent molecule into DNA. Kinetics of ethidium bromide
uptake from t 0 min onward were measured for 40 min at room temperature. Results of three independent experiments are shown. Fluorescent intensities were
normalized against autofluorescence of ethidium bromide in uptake buffer and are depicted relative to the maximal intensity measured. (B) The relative fluorescent
intensity increase after 40 min was calculated for all strains with and without CCCP treatment and statistically analyzed by one-way ANOVA and Tukey’s Multiple
Comparison Test (∗∗P < 0.05; ∗∗∗P < 0.001). Error bars reflect the standard deviation in three independent experiments. (C) Growth curve in Middlebrook
7H9-OADC-Tween at 37◦C with regular shaking for M. abscessus WT, 1pmt and 1pmt::pmt. Results of three independent experiments with standard deviations are
depicted. (D) Survival of M. abscessus WT, 1pmt and 1pmt::pmt in THP-1 macrophages 3 days after infection. Results of multiple independent experiments are
shown (WT: n = 3; 1pmt: n = 3; 1pmt::pmt: n = 2). One-way ANOVA and Tukey’s Multiple Comparison Test statistical analysis were performed (∗∗∗P < 0.001).
localization of specific lipoproteins is altered upon glycosylation
deficiency. This could affect the cell envelope structure directly
or interfere with the homeostasis through indirect alterations
in membrane composition. In M. tuberculosis, lipoproteins
such as LpqW (conversion of phosphoinositol mannosides
to lipomannans and lipoarabinomannans) or LppX (transport
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of phthiocerol dimycocerosates) for instance are important
players in the synthesis and transport of cell wall components,
respectively (Sulzenbacher et al., 2006; Rainczuk et al., 2012).
Homologs of LpqW (MAB_1315) and the LppX_LprAFG
superfamily (MAB_2806) are encoded in M. abscessus. Incorrect
localization of these or other lipoproteins in M. abscessus 1pmt
could affect cell wall homeostasis because their substrates might
not be synthesized or located correctly.
Based on the obtained results it cannot be excluded that
Pmt possess an additional function independent of lipoprotein
glycosylation that leads to the observed phenotypes. The
enzyme might be involved in the glycosylation of other (non-
lipo-) proteins but does not play a role in lipomannan or
lipoarabinomannan synthesis (Liu et al., 2013). Due to the
specific localization of lipoproteins in the cell envelope, however,
it is plausible that the observed phenotypes are assigned to a
deficiency in lipoprotein glycosylation. Pmt deletion mutants of
M. smegmatis and M. tuberculosis have been investigated (Liu
et al., 2013). The fast-growing, non-pathogenic M. smegmatis
1pmt strain showed WT-like growth and susceptibility to the
antibiotic ciprofloxacin while exhibiting only slightly decreased
tolerance to cell wall stress by SDS. Electron microscopy analysis
of the cell surface did not reveal obvious structural alterations
and intracellular survival of the mutant was not assessed.
Interestingly, the slow-growing, pathogenicM. tuberculosis1pmt
strain, however, was attenuated in in vitro growth and showed
reduced virulence in immunocompromised mice (Liu et al.,
2013). The observed phenotype was very recently attributed to
increased lipoarabinomannan production in the 1pmt strain
and secretion of this molecule partly bound to LprG. This
led to a stronger inflammatory response via TLR-2 activation
and could be a rationale for the attenuated virulence of
M. tuberculosis 1pmt (Alonso et al., 2017) and thus potentially
also of M. abscessus 1pmt. However, in the fast-growing
pathogenic M. abscessus we see an intermediate phenotype:
attenuated survival in macrophages but no in vitro growth
defect. It is tempting to speculate that the growth rate of the
mycobacterial species could affect the severity of the glycosylation
deficient phenotype and that lipoprotein glycosylation is more
crucial in pathogenic mycobacteria but this requires further
investigation.
It will be of interest to explore the detailed downstream
effects of lipoprotein glycosylation deficiency on the cell
envelope permeability of M. abscessus in order to elucidate
how the observed phenotypes arise on a molecular level.
Furthermore, it remains an open question how glycosylation
is exclusively directed to the N-terminal region of lipoproteins
in all mycobacterial species investigated so far and whether
mannose chain length is regulated and conserved. The results
of this study contribute to a more detailed understanding of the
fundamental biology and the drug resistance of the emerging
pathogen M. abscessus. They can be used as a foundation for
further exploration of lipoproteins in the context of the complex
mycobacterial cell envelope in non-tuberculous but pathogenic
mycobacteria.
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